Orchestra BioMed OBIO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 4.15 | 54 | 12.84 | 6 | 5.69 | 115 |
| 2025Q3 | 2.48 | 44 | -94.60 | -21 | -28.22 | 105 |
| 2025Q2 | 2.68 | 0 | -225.78 | -19 | -38.01 | 43 |
| 2025Q1 | 4.28 | 17 | -75.30 | -19 | -27.74 | 59 |
| 2024Q4 | 4.00 | 33 | -40.81 | -16 | -21.33 | 76 |
| 2024Q3 | 5.14 | 46 | -34.15 | -15 | -20.89 | 75 |
| 2024Q2 | 8.15 | 44 | -31.55 | -16 | -20.62 | 72 |
| 2024Q1 | 5.27 | 57 | -21.50 | -13 | -15.14 | 83 |
| 2023Q4 | 9.13 | 68 | -17.36 | -13 | -12.12 | 95 |
| 2023Q3 | 8.72 | 80 | -15.75 | -13 | -10.99 | 116 |
| 2023Q2 | 7.00 | 89 | -12.73 | -12 | -9.19 | 126 |
| 2023Q1 | 19.57 | 100 | -11 | -10.71 | 136 | |
| 2022Q4 | 9.98 | -7 | -1 | -1.28 | 68 | |
| 2022Q3 | 9.90 | -6 | -10 | -8.93 | 69 | |
| 2022Q2 | 9.96 | -5 | -8 | -4.86 | 162 | |
| 2022Q1 | 9.91 | -4 | -6 | -6.55 | 162 | |
| 2021Q4 | 10.08 | -71 | 14 |